Identifying chemokines as therapeutic targets in renal disease: lessons from antagonist studies and knockout mice.
Chemokines, in concert with cytokines and adhesion molecules, play multiple roles in local and systemic immune responses. In the kidney, the temporal and spatial expression of chemokines correlates with local renal damage and accumulation of chemokine receptor-bearing leukocytes. Chemokines play important roles in leukocyte trafficking and blocking chemokines can effectively reduce renal leukocyte recruitment and subsequent renal damage. However, recent data indicate that blocking chemokine or chemokine receptor activity in renal disease may also exacerbate renal inflammation under certain conditions. An increasing amount of data indicates additional roles of chemokines in the regulation of innate and adaptive immune responses, which may adversively affect the outcome of interventional studies. This review summarizes available in vivo studies on the blockade of chemokines and chemokine receptors in kidney diseases, with a special focus on the therapeutic potential of anti-chemokine strategies, including potential side effects, in renal disease.
Medizinische Poliklinik Innenstadt, Klinikum der Universität München, Ludwig Maximilians University, Munich, Germany. V.Vielhauer@lrz.uni-muenchen.de
Volker
V
Vielhauer
Vaclav
V
Eis
Detlef
D
Schlöndorff
Hans-Joachim
HJ
Anders
D000818:Animals; D018925:Chemokines / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000276:immunology*; D007668:Kidney / Q000276:immunology*; D051379:Mice; D018345:Mice, Knockout; D051437:Renal Insufficiency / Q000276:immunology* / Q000628:therapy*
D018925:Chemokines